scholarly journals Two Uncommon Causes of Guillain-Barré Syndrome: Hepatitis E and Japanese Encephalitis

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Dhrubajyoti Bandyopadhyay ◽  
Vijayan Ganesan ◽  
Cankatika Choudhury ◽  
Suvrendu Sankar Kar ◽  
Parthasarathi Karmakar ◽  
...  

We are presenting two cases of Guillain-Barré syndrome where it is preceded by hepatitis E virus (HEV) and Japanese encephalitis virus (JEV) infection, respectively. Our first case is a forty-three-year-old nondiabetic, nonhypertensive female who was initially diagnosed with acute HEV induced viral hepatitis and subsequently developed acute onset ascending quadriparesis with lower motor neuron type of bilateral facial nerve palsies and respiratory failure. Second patient was a 14-year-old young male who presented with meningoencephalitis with acute onset symmetric flaccid paraparesis. After thorough investigations it was revealed as a case of Japanese encephalitis. Our idea of reporting these two cases is to make ourselves aware about this potential complication of these two common infections.

Infection ◽  
2011 ◽  
Vol 40 (3) ◽  
pp. 323-326 ◽  
Author(s):  
I. Maurissen ◽  
A. Jeurissen ◽  
T. Strauven ◽  
D. Sprengers ◽  
B. De Schepper

2017 ◽  
Vol 142 (11) ◽  
pp. 833-837
Author(s):  
Heiner Wedemeyer

Was ist neu? Übertragungswege In Deutschland infizieren sich jedes Jahr wahrscheinlich mehr als 300 000 Menschen mit dem Hepatitis-E-Virus (HEV). Die Hepatitis E ist in Mitteleuropa in der Regel eine durch den zoonotischen HEV-Genotyp-3-verursachte autochthone, d. h. lokal erworbene Infektionskrankheit. Der Verzehr von nicht ausreichend erhitztem Schweine- oder Wildfleisch ist ein Hauptrisikofaktor für HEV-Infektionen, Übertragungen des Virus durch Bluttransfusionen sind aber auch möglich. Diagnostik Bei Immunkompetenten kann die Diagnose einer akuten Hepatitis E mit dem Nachweis von anti-HEV-IgM gestellt werden. Serologische Tests können bei Immunsupprimierten aber falsch-negativ sein, weshalb in diesen Fällen eine HEV-Infektion nur durch den direkten Nachweis des Erregers mittels PCR im Blut oder Stuhl erfolgen sollte. Natürlicher Verlauf Eine akute Hepatitis E kann bei Patienten mit anderen chronischen Lebererkrankungen zu einem Leberversagen führen. Chronische Verläufe, definiert durch eine Virämie von mind. 3 Monaten, sind bei Organtransplantierten mit immunsuppressiver Medikation beschrieben, können aber auch bei anderen Immundefizienzen auftreten. Eine chronische Hepatitis E kann innerhalb von Monaten zu einer fortgeschrittenen Leberfibrose oder zur Zirrhose führen. Extrahepatische Manifestationen Extrahepatische Manifestationen können während und nach einer HEV-Infektion auftreten. Insbesondere Guillain-Barré-Syndrome und die neuralgische Schulteramyotrophie sind mit einer Hepatitis E assoziiert worden. Therapie Ribavirin hat eine antivirale Wirksamkeit gegen HEV. Bei chronischer Hepatitis E sollte die Behandlung für 3 – 6 Monate durchgeführt werden. Therapieversagen und Rückfälle nach Beendigung einer Behandlung sind möglich. Ein Impfstoff gegen HEV ist bisher nur in China zugelassen.


2017 ◽  
Vol 74 (1) ◽  
pp. 13 ◽  
Author(s):  
Kenneth L. Tyler ◽  
Daniel M. Pastula

BMC Neurology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Miriam Fritz-Weltin ◽  
Estelle Frommherz ◽  
Nora Isenmann ◽  
Lisa Niedermeier ◽  
Benedikt Csernalabics ◽  
...  

Abstract Background Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis worldwide. An association with neuralgic amyotrophy and Guillain-Barré syndrome (GBS) was previously described. Concerning GBS, studies from other countries found an acute HEV infection in 5–11% of cases. However, HEV prevalence shows considerable regional variations. Therefore, we retrospectively analyzed the frequency of HEV infections in association with GBS in a monocentric cohort in Southwestern Germany. Methods Overall, 163 patients with GBS treated in our clinic between 2008 and 2018 of whom serum and/or cerebrospinal fluid (CSF) samples were available, were identified. Serum samples were analyzed for anti-HEV immunoglobulin (Ig)M and IgG antibodies by ELISA. Additionally, both serum and cerebrospinal fluid (CSF) samples were tested for HEV RNA by PCR if IgM was positive or patients presented within the first 7 days from GBS symptom onset. A group of 167 healthy volunteers and 96 healthy blood donors served as controls. Results An acute HEV infection was found in two GBS patients (1.2%) with anti-HEV IgM and IgG antibodies. HEV PCR in serum and CSF was negative in these two patients as well as in all other tested cases. Seroprevalences indicated that acute infection did not differ significantly from controls (0.8%). Anti-HEV IgG seroprevalence indicating previous infection was unexpectedly high (41%) and revealed an age-dependent increase to more than 50% in patients older than 60 years. Conclusion In this study, serological evidence of an acute HEV infection in patients with GBS was rare and not different from controls. Comparing our data with previous studies, incidence rates show considerable regional variations.


Author(s):  
Monami Tarisawa ◽  
Ryo Ando ◽  
Katsuki Eguchi ◽  
Megumi Abe ◽  
Masaaki Matsushima ◽  
...  

2017 ◽  
Vol 74 (1) ◽  
pp. 26 ◽  
Author(s):  
Olivier Stevens ◽  
Kristl G. Claeys ◽  
Koen Poesen ◽  
Veroniek Saegeman ◽  
Philip Van Damme

Infection ◽  
2013 ◽  
Vol 42 (1) ◽  
pp. 171-173 ◽  
Author(s):  
N. Scharn ◽  
T. Ganzenmueller ◽  
J. J. Wenzel ◽  
R. Dengler ◽  
A. Heim ◽  
...  

2021 ◽  
Vol 41 (4) ◽  
pp. 47-53
Author(s):  
Mariah Q. Rose ◽  
Christan D. Santos ◽  
Devon I. Rubin ◽  
Jason L. Siegel ◽  
William D. Freeman

Introduction Guillain-Barré syndrome precipitated by hepatitis E virus infection is rare, yet its incidence is increasing. Clinical Findings A 57-year-old man was transferred from another facility with fatigue, orange urine, and progressive weakness over 4 to 6 weeks. Initial laboratory results included total bilirubin, 9.0 mg/dL; direct bilirubin, 6.4 mg/dL; aspartate aminotransferase, 1551 U/L; alanine aminotransferase, 3872 U/L; and alkaline phosphatase, 430 U/L. Immunoglobulin M and quantitative polymerase chain reaction test results were positive for hepatitis E virus. Contrast-enhanced magnetic resonance imaging of the brain and spine showed no gross abnormalities. Analysis of cerebrospinal fluid obtained by lumbar puncture revealed the following (reference values in parentheses): total white blood cell count, 15/μL (0–5/μL), with 33% neutrophils and 54% lymphocytes; protein, 0.045 g/dL (0.015–0.045 g/dL); and glucose, 95 mg/dL (within reference range). Neurological examination revealed weakness in both upper extremities, with proximal strength greater than distal strength. The patient could not elevate either lower extremity off the bed and had areflexia and reduced sensation throughout all extremities. Diagnosis Guillain-Barré syndrome secondary to acute hepatitis E virus infection was diagnosed on the basis of clinical characteristics, serum and cerebrospinal fluid analyses, and nerve conduction studies. Conclusions Nurses and clinicians should obtain a thorough history and consider hepatitis E virus infection as a precipitating factor in patients with sensory and motor disturbances consistent with Guillain-Barré syndrome. The case gives insight into the diagnostic process for Guillain-Barré syndrome and highlights the vital role of bedside nurses in evaluating and treating these patients.


Neurology ◽  
2014 ◽  
Vol 82 (6) ◽  
pp. 491-497 ◽  
Author(s):  
B. van den Berg ◽  
A. A. van der Eijk ◽  
S. D. Pas ◽  
J. G. Hunter ◽  
R. G. Madden ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document